From the Editor-in-Chief
Analysis of big data in cancer medicine will be key to delivering on the cancer moonshot.
by William G. Nelson, MD, PhD
Watching and waiting for cancer to progress can be an alternative to active treatment.
by Kevin McLaughlin
Getting to the Root of Brain Cancer | Determining Value | Cancer Centers Unite to Increase HPV Vaccination Rates | Breast Cancer Survivors and Vaginal Estrogen | PET Scan Overuse | A Report Card on Active Surveillance | Radiation Appointments Are Numerous, And Necessary | Vice President Joe Biden Brings "Moonshot" to AACR Annual Meeting
Your Cancer Guide
Give yourself permission to appreciate your good fortune, despite knowing others who have not fared as well.
by Hester Hill Schnipper
Caregiving With Confidence
Caregiving is difficult, but it can bring rewards.
by Carly O'Brien
Retired Army colonel and prostate cancer survivor Jim Williams asks men to pay better attention to their health.
by Lauren Gravitz
For patients with chronic blood cancers, the early intervention mantra of cancer does not always apply.
by Sue Rochman
Yesterday & Today
Whether playing Franklin D. Roosevelt or Richard Gilmore, the wealthy scion in 'Gilmore Girls,' Edward Herrmann took on gentlemanly roles that mirrored his real-life persona. He died of brain cancer in 2014.
by Marilyn Fenichel
Bacteria can be friend or foe—or both. Researchers are looking at bacteria to boost the effectiveness of cancer treatments, even if they don't fully understand how the tiny organisms work.
by Stephen Ornes
A Matter of Taste | Bolstering the Brain
Psychiatrist Andrew Roth helps prostate cancer patients identify and take control of their emotions.
by Kate Yandell
Give the gift of music to young cancer patients.
Fran Keilt, Virginia White, Barbara Rascati.
Survival statistics are important—and sometimes confusing. Cancer Today spoke with statistics experts about what these numbers really mean.
by Ashley P. Taylor
Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus.
by Marcus A. Banks
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
The AACR led a contingent of 130 organizations in asking that cancer patients and survivors be granted high priority in receiving COVID-19 vaccinations.
Eliminating disparities requires consistent effort on numerous fronts, including the development and sustenance of a diverse scientific workforce.
In March of last year, screenings for breast, colon and cervical cancer decreased by roughly 90% compared with historical rates.
Learning Medicare’s ABCDs
donate to the AACR